Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services

CourtDrug Enforcement Administration
Citation88 FR 63618
Published date15 September 2023
Record Number2023-19988
SectionNotices
Federal Register, Volume 88 Issue 178 (Friday, September 15, 2023)
[Federal Register Volume 88, Number 178 (Friday, September 15, 2023)]
                [Notices]
                [Pages 63618-63619]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2023-19988]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF JUSTICE
                Drug Enforcement Administration
                [Docket No. DEA-1263]
                Importer of Controlled Substances Application: AndersonBrecon,
                Inc. DBA PCI Pharma Services
                AGENCY: Drug Enforcement Administration, Justice.
                ACTION: Notice of application.
                -----------------------------------------------------------------------
                SUMMARY: AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be
                registered as an importer of basic class(es) of controlled
                substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
                further drug information.
                DATES: Registered bulk manufacturers of the affected basic class(es),
                and applicants therefore, may submit electronic comments on or
                objections to the issuance of the proposed registration on or before
                October 16, 2023. Such persons may also file a written request for a
                hearing on the application on or before October 16, 2023.
                ADDRESSES: The Drug Enforcement Administration requires that all
                comments be submitted electronically through the Federal eRulemaking
                Portal, which provides the ability to type short comments directly into
                the comment field on the web page or attach a file for lengthier
                comments. Please go to https://www.regulations.gov and follow the
                online instructions at that site for submitting comments. Upon
                submission of your comment, you will receive a Comment Tracking Number.
                Please be aware that submitted comments are not instantaneously
                available for public view on https://www.regulations.gov. If you have
                received a Comment Tracking Number, your comment has been successfully
                submitted and there is no need to resubmit the same comment. All
                requests for a hearing must be sent to: (1) Drug Enforcement
                Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
                Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
                Attn: DEA Federal
                [[Page 63619]]
                Register Representative/DPW, 8701 Morrissette Drive, Springfield,
                Virginia 22152. All requests for a hearing should also be sent to: Drug
                Enforcement Administration, Attn: Administrator, 8701 Morrissette
                Drive, Springfield, Virginia 22152.
                SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
                is notice that on July 27, 2023, AndersonBrecon, Inc. DBA PCI Pharma
                Services, 4545 Assembly Drive, Rockford, Illinois 61109-3081, applied
                to be registered as an importer of the following basic class(es) of
                controlled substance(s):
                ------------------------------------------------------------------------
                 Drug
                 Controlled substance code Schedule
                ------------------------------------------------------------------------
                Dimethyltryptamine...................... 7435 I
                ------------------------------------------------------------------------
                 The company plans to import the listed controlled substances for
                clinical trials. No other activity for this drug code is authorized for
                this registration.
                 Approval of permit applications will occur only when the
                registrant's business activity is consistent with what is authorized
                under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
                of Food and Drug Administration-approved or non-approved finished
                dosage forms for commercial sale.
                Claude Redd,
                Acting Deputy Assistant Administrator.
                [FR Doc. 2023-19988 Filed 9-14-23; 8:45 am]
                BILLING CODE 4410-09-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT